Skip to content

Anbio Biotechnology

NNNN

CIK 0001982708

← back to feed
Revenue (TTM)
$8.65M
+5.6% YoY FY Dec 2025
Net Income (TTM)
$6.4M
+169.9% YoY FY Dec 2025
EPS Diluted (TTM)
$0.15
+162.5% YoY FY Dec 2025
Gross Margin
87.2%
FY Dec 2025
Operating Margin
66.7%
FY Dec 2025
Net Margin
74.1%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$7.77M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
—
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings